Litcius/Paper detail

Novel Albumin Gel-platelet-rich fibrin mixture (Alb-PRF); where do we stand?

V. Manjunatha, Trinath Kishore Damera, Akshay Kumar T K, Velicheti Sai Chandini, Tanmay Popat, Devanshi Vala

2022International Journal of Clinical Biochemistry and Research10 citationsDOIOpen Access PDF

Abstract

AlbPRF is a blood by-product, without additives, using only autologous blood, which after centrifugation will be produced in two stages: heating and incorporation: heating of the serum and low platelet plasma and incorporation of cells (GF and PRF cytokines liquid, removed from the junction of the leukocyte zone and the red blood cells). This new biomaterial has already been tested in vitro and translational research with this new material has already started. Excellent results can be expected from the use of AlbPRF, not only for oral/periodontal surgery applications but also for use in facial medicine and aesthetics.

Topics & Concepts

FibrinPlatelet-rich fibrinBiomaterialCentrifugationPlateletAlbuminBiomedical engineeringPlatelet-rich plasmaMaterials sciencePlatelet concentrateIn vitroBlood productBlood proteinsFibrinogenBiologyImmunologyBiochemistryPathologyMedicinePeriodontal Regeneration and TreatmentsOral and gingival health researchOral and Maxillofacial Pathology
Novel Albumin Gel-platelet-rich fibrin mixture (Alb-PRF); where do we stand? | Litcius